1190 related articles for article (PubMed ID: 31628992)
1. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases.
Gubert C; Kong G; Renoir T; Hannan AJ
Neurobiol Dis; 2020 Feb; 134():104621. PubMed ID: 31628992
[TBL] [Abstract][Full Text] [Related]
2. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota and Disorders of the Central Nervous System.
Vuotto C; Battistini L; Caltagirone C; Borsellino G
Neuroscientist; 2020; 26(5-6):487-502. PubMed ID: 32441219
[TBL] [Abstract][Full Text] [Related]
4. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
Chen Y; Xu J; Chen Y
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205336
[TBL] [Abstract][Full Text] [Related]
6. Influence of gut microbiota on neuropsychiatric disorders.
Cenit MC; Sanz Y; Codoñer-Franch P
World J Gastroenterol; 2017 Aug; 23(30):5486-5498. PubMed ID: 28852308
[TBL] [Abstract][Full Text] [Related]
7. Gut dysbiosis and age-related neurological diseases in females.
Korf JM; Ganesh BP; McCullough LD
Neurobiol Dis; 2022 Jun; 168():105695. PubMed ID: 35307514
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.
Ghaisas S; Maher J; Kanthasamy A
Pharmacol Ther; 2016 Feb; 158():52-62. PubMed ID: 26627987
[TBL] [Abstract][Full Text] [Related]
9. Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects.
Caballero-Villarraso J; Galvan A; Escribano BM; Tunez I
CNS Neurol Disord Drug Targets; 2017; 16(8):945-964. PubMed ID: 28714393
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in understanding the role of the gut microbiota in brain health and disease.
Sherwin E; Dinan TG; Cryan JF
Ann N Y Acad Sci; 2018 May; 1420(1):5-25. PubMed ID: 28768369
[TBL] [Abstract][Full Text] [Related]
11. Dietary polyphenols represent a phytotherapeutic alternative for gut dysbiosis associated neurodegeneration: A systematic review.
Chatterjee A; Kumar S; Roy Sarkar S; Halder R; Kumari R; Banerjee S; Sarkar B
J Nutr Biochem; 2024 Jul; 129():109622. PubMed ID: 38490348
[TBL] [Abstract][Full Text] [Related]
12. Gut Microbiota and Neurologic Diseases and Injuries.
Tyler Patterson T; Grandhi R
Adv Exp Med Biol; 2020; 1238():73-91. PubMed ID: 32323181
[TBL] [Abstract][Full Text] [Related]
13. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics.
Banerjee A; Pradhan LK; Sahoo PK; Jena KK; Chauhan NR; Chauhan S; Das SK
Arch Microbiol; 2021 Aug; 203(6):2895-2910. PubMed ID: 33763767
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics analysis of microbiota-gut-brain axis in neurodegenerative and psychiatric diseases.
Konjevod M; Nikolac Perkovic M; Sáiz J; Svob Strac D; Barbas C; Rojo D
J Pharm Biomed Anal; 2021 Feb; 194():113681. PubMed ID: 33279302
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
[TBL] [Abstract][Full Text] [Related]
16. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
17. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.
Quigley EMM
Curr Neurol Neurosci Rep; 2017 Oct; 17(12):94. PubMed ID: 29039142
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
Front Immunol; 2022; 13():937555. PubMed ID: 35812394
[TBL] [Abstract][Full Text] [Related]
19. Targeting the microbiota in pharmacology of psychiatric disorders.
Pascale A; Marchesi N; Govoni S; Barbieri A
Pharmacol Res; 2020 Jul; 157():104856. PubMed ID: 32389857
[TBL] [Abstract][Full Text] [Related]
20. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.
Westfall S; Lomis N; Kahouli I; Dia SY; Singh SP; Prakash S
Cell Mol Life Sci; 2017 Oct; 74(20):3769-3787. PubMed ID: 28643167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
